Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

(MedPage Today) — The FDA approved an allogeneic regulatory T cell-based immunotherapy product with hematopoietic stem and progenitor cells (HSPCs) and T cells (Tregzi) to prevent serious complications of stem cell transplants for hematologic…